Aimei Health Technology Co., Ltd Ordinary Share (AFJK) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Aimei Health Technology Co., Ltd Ordinary Share stock (AFJK) is currently trading at $26.22. Aimei Health Technology Co., Ltd Ordinary Share PE ratio is 137.50. WallStSmart rates AFJK as Sell.
- AFJK PE ratio analysis and historical PE chart
- AFJK PS ratio (Price-to-Sales) history and trend
- AFJK intrinsic value — DCF, Graham Number, EPV models
- AFJK stock price prediction 2025 2026 2027 2028 2029 2030
- AFJK fair value vs current price
- AFJK insider transactions and insider buying
- Is AFJK undervalued or overvalued?
- Aimei Health Technology Co., Ltd Ordinary Share financial analysis — revenue, earnings, cash flow
- AFJK Piotroski F-Score and Altman Z-Score
- AFJK analyst price target and Smart Rating
Aimei Health Technology Co., Ltd Ordinary Share
📊 No data available
Try selecting a different time range
AFJK Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
AFJK trades 3449% above its Graham fair value of $1.36, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Aimei Health Technology Co., Ltd Ordinary Share (AFJK) · 4 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Concerns around market cap and eps growth. Significant fundamental concerns warrant caution or avoidance.
Aimei Health Technology Co., Ltd Ordinary Share (AFJK) Key Strengths (0)
Aimei Health Technology Co., Ltd Ordinary Share (AFJK) Areas to Watch (4)
Earnings declining -30.20%, profits shrinking
Micro-cap company with very limited liquidity and high volatility
Premium pricing at 4.0x book value
Low institutional interest, mostly retail-driven
Supporting Valuation Data
Aimei Health Technology Co., Ltd Ordinary Share (AFJK) Detailed Analysis Report
Overall Assessment
This company scores 10/100 in our Smart Analysis, earning a F grade. Out of 4 metrics analyzed, 0 register as strengths (avg 0/10) while 4 fall into concern territory (avg 2.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
Limited fundamental strengths were identified. The bull case requires improvement in core metrics.
The Bear Case
The primary concerns are EPS Growth, Market Cap, Price/Book. Some valuation metrics including Price/Book (4.01) suggest expensive pricing. Growth concerns include EPS Growth at -30.20%, which may limit upside.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, overall profitability trends. Third, growth sustainability, with EPS Growth at -30.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Market Cap are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AFJK Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
Insider Transactions
Loading insider activity...
About Aimei Health Technology Co., Ltd Ordinary Share(AFJK)
NASDAQ
FINANCIAL SERVICES
SHELL COMPANIES
USA
Aimei Health Technology Co., Ltd. is a pioneering healthcare technology firm committed to revolutionizing health solutions through advanced digital platforms and medical devices. With a strong emphasis on improving patient outcomes and streamlining healthcare delivery, the company is a leader in the rapidly expanding telehealth and personalized medicine markets. Leveraging artificial intelligence and data analytics, Aimei enhances operational efficiency within healthcare systems, establishing itself as a vital player in the evolving health tech sector. Its strategic dedication to innovation positions Aimei for substantial growth and influence in driving the future of healthcare.